Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,378 across all filing types
Latest filing 2019-08-19 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
NOTIFICATION OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from Yanzhou Coal Mining Company Limited notifying the market and shareholders of an upcoming board meeting scheduled for 30 August 2019. The purpose of the meeting includes considering the publication of the unaudited interim results for the six months ended 30 June 2019. The document does not contain any financial data or the actual interim results; it merely announces the meeting date and agenda. The document length is only 1535 characters, which is quite short and consistent with an announcement rather than a full report. According to the rules, announcements about upcoming reports or meetings are classified as Regulatory Filings (RNS) unless they contain substantive financial data or detailed report content. Therefore, this document is best classified as a Regulatory Filing (RNS).
2019-08-19 English
VOLUNTARY ANNOUNCEMENT-ABSTRACT ON CSTONE'S CS1001-101 CLINICAL TRIAL ACCEPTED FOR POSTER PRESENTATION AT ESMO 2019 ANNUAL CONGRESS
Regulatory Filings Classification · 90% confidence The document is a voluntary announcement by CStone Pharmaceuticals regarding the acceptance of an abstract on their clinical trial for poster presentation at a medical congress (ESMO 2019 Annual Congress). It discusses clinical trial data and company information but does not contain financial statements, regulatory filings, or detailed financial results. It is not an annual or interim report, earnings release, or any form of financial or governance report. The document is an announcement of scientific and clinical progress, which does not fit into the typical financial or regulatory filing categories. Given the nature of the content and the absence of financial or regulatory data, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2019-08-16 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-08-16 English
ANNOUNCEMENT ON TERMINATION OF NON-PUBLIC ISSUANCE OF A SHARES AND WITHDRAWAL OF APPLICATION MATERIALS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the termination of a planned non-public issuance of A shares by Yanzhou Coal Mining Company Limited. It details the decision to withdraw application materials from the China Securities Regulatory Commission (CSRC) and explains the reasons for termination, the approval process, and the impact on the company. The document references prior announcements and circulars but does not contain financial statements or detailed financial data itself. It is a formal announcement about a capital raising activity that will no longer proceed, rather than a report or detailed financial disclosure. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is sufficient and the content is substantive about financing activities, not merely a brief notice or regulatory filing. Hence, the classification is CAP with high confidence.
2019-08-16 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-08-16 English
ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE TWENTY-SIXTH MEETING OF THE SEVENTH SESSION OF THE BOARD OF DIRECTORS
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting, detailing decisions such as termination of a share issuance and organizational adjustments. It is not a full report but a formal announcement of board decisions. The content aligns with Board/Management Information (MANG) as it relates to board resolutions and company management structure changes. The document length is short and it is an announcement, not a detailed report or financial statement.
2019-08-16 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.